“LakePharma’s (now part of Curia) high-efficiency fusion process combined with high throughput screening capabilities enabled identification of a lead antibody with a rare epitope and unique pharmacology.”
Vahe Bedian, Ph.D. Former CSO of Quellis Biosciences
“LakePharma (now part of Curia) is nothing short of a true partner with Apollos Diagnostics. We will continue to work with LakePharma (now part of Curia) as a partner for all of our future antibody development campaigns.”
John Alderete, Ph.D., MBA Founder and President of Folium Biomed, LLC
“LakePharma (now part of Curia) is a great partner to work with. Their expertise enables them to generate large panels of antibodies that can be used as the foundation for our therapeutic candidates.“
